Viewing Study NCT02067156


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-13 @ 3:38 AM
Study NCT ID: NCT02067156
Status: COMPLETED
Last Update Posted: 2024-05-21
First Post: 2014-02-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
Sponsor: GenSpera, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-02
Start Date Type: ACTUAL
Primary Completion Date: 2016-12
Primary Completion Date Type: ACTUAL
Completion Date: 2017-02
Completion Date Type: ACTUAL
First Submit Date: 2014-02-16
First Submit QC Date: None
Study First Post Date: 2014-02-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-03-22
Results First Submit QC Date: None
Results First Post Date: 2024-05-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-16
Last Update Post Date: 2024-05-21
Last Update Post Date Type: ACTUAL